Who we are

Steve Kalloger - Principal Consultant

Steve Kalloger is an oncology researcher, evidence-generation leader, and decision scientist with more than 30 years of experience across academic medicine, healthcare, global patient advocacy, and industry-facing research.

His work spans real-world evidence, health economics and outcomes research, patient-preference research, mixed methods, statistical analysis, translational research, and scientific publication. He has authored or co-authored more than 120 peer-reviewed publications and has led international research programs addressing clinical, patient, and health-system evidence needs.

Steve founded Kalloger Consulting to provide organizations with senior-level scientific support that combines methodological rigor, strategic judgment, and practical execution.

Shari Davidson - Managing Partner, Operations

Shari Davidson is Co-Founder, Chief Operating Officer and an equal partner in Haute Earth LLC. With more than 30 years of experience in business management and real estate investment, she leads the firm’s financial operations, administration, project coordination, and fulfillment.

Shari works closely with clients and project partners to ensure that engagements are well organized, responsive, and delivered as promised. As an officer and co-owner of the company, she has full authority to represent the firm and plays a central role in its operational and financial leadership.

    • Head, Research, Lymphoma Coalition
      Led international research and evidence-generation initiatives addressing patient, clinical, and health-system priorities in lymphoma.

    • Adjunct Professor, University of British Columbia
      More than 15 years teaching and mentoring in research methods, biostatistics, experimental design, and scientific communication.

    • Principal Consultant, Kalloger Consulting
      Provides senior-level support in oncology evidence strategy, real-world evidence, HEOR, decision science, mixed methods, and scientific communication.

    • International oncology researcher and collaborator
      More than 30 years of experience spanning academic medicine, healthcare, industry-facing research, and global patient advocacy.

    • Author or co-author of more than 120 peer-reviewed publications
      Work across oncology, pathology, biomarkers, outcomes research, patient preferences, and health-services research.

  • Our research is broadly categorized into four major themes:

    Oncology and biomarker research

    Clinical and real-world outcomes

    Patient preferences and decision science

    Research methodology or evidence translation

    A full list of peer reviewed publications is available at the following links:

    Google Scholar

    https://tinyurl.com/2krmadrx

    PubMed

    https://tinyurl.com/54ya5ju7

  • Evidence strategy

    • Identifying evidence gaps affecting clinical, payer, regulatory, or patient decisions

    • Developing integrated evidence-generation plans

    • Prioritizing research questions across a product or disease-area lifecycle

    • Assessing whether existing evidence is sufficient to support a strategic claim

    Real-world evidence and outcomes research

    • Designing retrospective observational studies

    • Developing protocols and statistical analysis plans

    • Evaluating outcomes, treatment patterns, resource use, and unmet need

    • Interpreting real-world findings for clinical and strategic audiences

    Patient preferences and decision science

    • Designing discrete-choice experiments and preference studies

    • Conducting qualitative research to identify patient-relevant outcomes

    • Developing MCDA and structured decision-support frameworks

    • Incorporating patient priorities into evidence and value strategies

    Statistical and methodological support

    • Survival analysis and prognostic modelling

    • Biomarker prevalence and clinical-association studies

    • Sensitivity, uncertainty, and heterogeneity analyses

    • Independent review of methods, models, and analytical interpretation

    Scientific communication

    • Developing manuscripts, reports, abstracts, and conference materials

    • Strengthening the logic and defensibility of scientific narratives

    • Translating complex results for executives, payers, clinicians, and patient organizations

    • Supporting publication strategy and responses to peer review

    • Determine what evidence is required before making an important development or investment decision

    • Design a rigorous study without building a full internal research team

    • Understand whether a biomarker, outcome, or patient segment is clinically meaningful

    • Incorporate patient preferences into product, research, or policy decisions

    • Rescue an analysis or manuscript that has become methodologically or strategically unclear

    • Translate complex research into a report that senior decision-makers can act upon

    • Obtain an independent, candid assessment of whether the evidence truly supports the proposed conclusion

  • Kalloger Consulting Linkedin

    https://www.linkedin.com/company/115963988/admin/dashboard/

    Steve Kalloger Linkedin

    https://www.linkedin.com/in/stevekalloger/

Our mission is to: Improve Patient Outcomes Through Research Excellence

Have a complex evidence question?

Kalloger Consulting works with organizations that need senior scientific judgment, rigorous methods, and clear recommendations.

Discuss a project